TRIP13保护胰腺癌细胞免受内在和治疗诱导的DNA复制压力
Jay R Anand1, Gaith N Droby2, Sayali Joseph1
1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
NAR cancer
|March 21, 2025
概括
瘤基因激活会导致DNA复制压力,需要DNA损伤反应 (DDR) 才能生存. 我们发现TRIP13对KRAS突变胰腺癌细胞至关重要,提供了一个新的治疗点.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 遗传学 遗传学 是一个
背景情况:
- 正常细胞中的瘤基因激活会触发DNA复制压力,从而使得DNA损伤反应 (DDR) 途径对生存产生依赖.
- 在各种癌症中,DDR被病理性地改变,不同的瘤刺激采用独特的信号机制.
- 突变KRAS驱动90%的胰腺管道腺癌 (PDAC),突出需要了解KRAS诱导的DDR在这种癌症中.
研究的目的:
- 研究DDR机制,使正常人胰腺上皮细胞 (HPNE细胞) 能够容忍KRAS诱导的DNA复制应激.
- 为了确定参与KRAS驱动的胰腺癌的新型DDR参与者.
- 探索TRIP13作为KRAS突变PDAC中的潜在治疗漏洞.
主要方法:
- 候选查方法用于识别KRAS诱导的基因.
- 基因和药理工具来评估TRIP13在KRASG12V表达HPNE细胞中的功能.
- 对TRIP13贫乏细胞和PDAC细胞系中对基因毒剂和抑制剂的同源重组 (HR) 依赖性和敏感性的评估.
主要成果:
- 与正常组织相比,TRIP13 mRNA是由KRASG12V上调调节,并在PDAC中高度表达.
- TRIP13对于KRASG12V表达细胞中的DNA合成和活力至关重要.
- 在KRASG12V表达细胞中的TRIP13枯竭导致HR缺陷表型和对转化合成和PARP抑制剂的敏感性.
- TRIP13的枯竭使已建立的PDAC细胞系对DNA损伤和基因毒性疗法产生敏感性.
结论:
- TRIP13是一种KRASG12V诱导的基因,对维持DNA合成和KRAS突变胰腺细胞的存活至关重要.
- TRIP13以同类的重组依赖方式运行,其耗尽使其对与人力资源缺陷相关的负债敏感.
- TRIP13代表了KRAS突变胰腺管道腺癌的新和治疗可行的脆弱性.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Restarting Stalled Replication Forks
5.7K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.7K
The Intrinsic Apoptotic Pathway
5.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K
The DNA Replication Fork
35.3K
An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork. Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
35.3K


